Beta Bionics, Inc. - Common Stock (BBNX)

Historical Holders from Q1 2025 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
BBNX on Nasdaq
Shares outstanding
43,483,337
Price per share
$30.47
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
48,310,134
Total reported value
$959,915,542
% of total 13F portfolios
0%
Share change
+3,173,949
Value change
+$85,339,905
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
127
Price from insider filings
$30.10
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Beta Bionics, Inc. - Common Stock (BBNX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
EVENTIDE ASSET MANAGEMENT, LLC 11% $57,361,654 4,857,041 Eventide Asset Management, LLC 31 Jan 2025
Zone Healthcare Holdings, LLC 9.9% +25% $85,717,590 +$17,618,729 4,313,920 +26% Dapice Joshua J. 30 Sep 2025
Farallon Capital Partners, L.P. 9.7% $77,057,854 4,203,920 Dapice Joshua J. 30 Jun 2025
Wellington Hadley Harbor Aggregator IV, L.P. 9% +31% $46,077,884 +$11,810,000 3,901,599 +34% Wellington Hadley Harbor Aggregator IV, L.P. 31 Mar 2025
WELLINGTON MANAGEMENT GROUP LLP 9% $46,077,884 3,901,599 Wellington Management Group LLP 31 Mar 2025
Soleus BB SPV, LLC 8.8% $44,822,977 3,795,341 Soleus Capital Management, L.P. 31 Mar 2025
MORGAN STANLEY 8.6% +26% $74,305,196 +$16,109,185 3,739,567 +28% Morgan Stanley 30 Sep 2025
Sands Capital Life Sciences Pulse Fund II, L.P. 8.2% +13% $65,440,171 +$7,619,854 3,570,113 +13% Sands Capital Life Sciences Pulse Fund II. L.P. 30 Jun 2025
RTW INVESTMENTS, LP 7.6% $38,971,453 3,299,869 RTW Investments, LP 31 Mar 2025
BlackRock, Inc. 6.4% $55,215,708 2,778,764 BlackRock, Inc. 30 Sep 2025
VANGUARD GROUP INC 5.1% $44,035,596 2,216,185 The Vanguard Group 30 Sep 2025
PERCEPTIVE ADVISORS LLC 3.7% $23,760,695 1,593,608 Perceptive Advisors LLC 31 Mar 2025
MILLENNIUM MANAGEMENT LLC 1.8% -70% $15,835,993 -$29,602,207 796,964 -65% Millennium Management LLC 30 Sep 2025
As of 30 Sep 2025, Beta Bionics, Inc. - Common Stock (BBNX) has 127 institutional shareholders filing 13F forms. They hold 48,310,134 shares. .

Top 25 institutional shareholders own 101% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
EVENTIDE ASSET MANAGEMENT, LLC 11% 4,957,252 +0.5% 1.6% $98,500,197
FARALLON CAPITAL MANAGEMENT LLC 9.9% 4,313,920 +2.6% 0.48% $85,717,590
WELLINGTON MANAGEMENT GROUP LLP 9% 3,901,599 0% 0.01% $77,524,772
Soleus Capital Management, L.P. 8.9% 3,870,158 +1.3% 4.1% $76,900,039
MORGAN STANLEY 8.7% 3,761,583 +28% 0% $74,742,654
Sands Capital Alternatives, LLC 8.2% 3,570,113 0% 16% $70,938,145
RTW INVESTMENTS, LP 7.6% 3,299,191 0% 0.81% $65,554,925
BlackRock, Inc. 6.4% 2,781,331 +224% 0% $55,265,048
VANGUARD GROUP INC 5.1% 2,216,185 +213% 0% $44,035,595
Omega Fund Management, LLC 4.4% 1,920,125 -3.4% 17% $38,152,884
DEERFIELD MANAGEMENT COMPANY, L.P. 2.7% 1,168,415 0% 0.36% $23,216,406
Driehaus Capital Management LLC 2.4% 1,058,975 -8.7% 0.15% $21,041,833
GEODE CAPITAL MANAGEMENT, LLC 2.1% 917,553 +193% 0% $18,235,786
STATE STREET CORP 1.9% 826,302 +259% 0% $16,418,621
MILLENNIUM MANAGEMENT LLC 1.8% 796,964 +47% 0.01% $15,835,675
JANUS HENDERSON GROUP PLC 1.5% 650,825 -2.2% 0.01% $12,931,893
Vestal Point Capital, LP 1.4% 600,000 +9.1% 0.54% $11,922,000
MARSHALL WACE, LLP 1.4% 594,902 -3.3% 0.01% $11,820,702
Walleye Capital LLC 1.4% 591,187 +171% 0.1% $11,746,886
PRICE T ROWE ASSOCIATES INC /MD/ 1.1% 487,658 +53% 0% $9,691,000
GOLDMAN SACHS GROUP INC 0.92% 399,253 +28% 0% $7,933,157
LORD, ABBETT & CO. LLC 0.84% 364,448 -13% 0.02% $7,242,000
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.76% 330,692 +223% 0% $6,570,850
NORTHERN TRUST CORP 0.69% 298,060 +213% 0% $5,922,452
PURA VIDA INVESTMENTS, LLC 0.65% 281,250 0% 36% $5,588,438

Institutional Holders of Beta Bionics, Inc. - Common Stock (BBNX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q4 152,305 $4,640,793 +$4,583,723 3,047.01% 4
2025 Q3 48,310,134 $959,915,542 +$85,339,905 1,987% 127
2025 Q2 44,848,348 $652,883,600 +$53,846,942 1,456% 114
2025 Q1 41,702,710 $507,968,057 +$504,374,152 1,224% 102